Mark Mallon Ironwood Pharmaceuticals Inc (IRWD) insider trading activity

IRWD Quotes by TradingView

Mark Mallon is Chief Executive Officer of IRONWOOD PHARMACEUTICALS INC. Currently has a direct ownership of 470,605 shares of IRWD, which is worth approximately $3.05 Million. The most recent transaction as insider was on Feb 26, 2021, when has been sold 30,675 shares (Class A Common Stock) at a price of $9.11 per share, resulting in proceeds of $279,449. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 471K
0% 3M change
0% 12M change
Total Value Held $3.05 Million

Mark Mallon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 26 2021
SELL
Open market or private sale
$279,449 $9.11 p/Share
30,675 Reduced 6.12%
470,605 Class A Common Stock

Also insider at

NEO
NEOGENOMICS INC Healthcare
Chief Executive Officer
MM

Mark Mallon

Chief Executive Officer
Boston, MA

Track Institutional and Insider Activities on IRWD

Follow IRONWOOD PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IRWD shares.

Notify only if

Insider Trading

Get notified when an Ironwood Pharmaceuticals Inc insider buys or sells IRWD shares.

Notify only if

News

Receive news related to IRONWOOD PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IRWD